speb/financial-data huggingface dataset:
XENE cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 73000.00
XENE cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 161000.00
XENE income_statement (annual, 2025-12-31) — Net Income: -345910000.00
XENE income_statement (quarterly, 2025-12-31) — Net Income: -105261000.00
XENE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -345910000.00
XENE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -105261000.00
XENE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -345910000.00
XENE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -105261000.00
XENE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -345910000.00
XENE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -105261000.00
XENE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -345910000.00
XENE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -105261000.00
XENE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -345910000.00
XENE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -105261000.00
XENE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -345910000.00
XENE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -105261000.00
XENE income_statement (annual, 2025-12-31) — Net Interest Income: 26828000.00
XENE income_statement (quarterly, 2025-12-31) — Net Interest Income: 5340000.00
XENE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 218797000.00
XENE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 63015000.00
XENE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 26828000.00
XENE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 5340000.00
XENE balance_sheet (annual, 2025-12-31) — Net PPE: 15347000.00
XENE balance_sheet (quarterly, 2025-12-31) — Net PPE: 15347000.00
XENE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -799000.00
XENE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -318000.00
XENE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 581760000.00
XENE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 581760000.00
XENE balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 12864000.00
XENE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 12864000.00
XENE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 12864000.00
XENE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 12864000.00
XENE balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 7151000.00
XENE balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 7151000.00
XENE income_statement (annual, 2025-12-31) — Normalized EBITDA: -371875000.00
XENE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -108860000.00
XENE income_statement (annual, 2025-12-31) — Normalized Income: -347055800.00
XENE income_statement (quarterly, 2025-12-31) — Normalized Income: -105009400.00
XENE cash_flow (annual, 2025-12-31) — Operating Cash Flow: -279118000.00
XENE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -81481000.00
XENE cash_flow (annual, 2025-12-31) — Operating Gains Losses: 698000.00
XENE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 179000.00
XENE income_statement (annual, 2025-12-31) — Operating Income: -373070000.00
XENE income_statement (quarterly, 2025-12-31) — Operating Income: -109767000.00
XENE income_statement (annual, 2025-12-31) — Operating Revenue: 7500000.00
XENE income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
XENE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 80010790.00
XENE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 80010790.00
XENE balance_sheet (annual, 2025-12-31) — Other Current Assets: 10392000.00
XENE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 10392000.00
XENE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 335000.00
XENE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 335000.00
XENE income_statement (annual, 2025-12-31) — Other Gand A: 79632000.00
XENE income_statement (quarterly, 2025-12-31) — Other Gand A: 61372000.00
XENE income_statement (annual, 2025-12-31) — Other Income Expense: 1348000.00
XENE income_statement (quarterly, 2025-12-31) — Other Income Expense: -296000.00
XENE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1313000.00
XENE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 334000.00
XENE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 3199000.00
XENE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 3199000.00
XENE balance_sheet (annual, 2025-12-31) — Other Properties: 12127000.00
XENE balance_sheet (quarterly, 2025-12-31) — Other Properties: 12127000.00
XENE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 349723000.00
XENE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 349723000.00
XENE balance_sheet (annual, 2025-12-31) — Payables: 4198000.00
XENE balance_sheet (quarterly, 2025-12-31) — Payables: 4198000.00
XENE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 25800000.00
XENE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 25800000.00
XENE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 14460000.00
XENE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 14460000.00
XENE income_statement (annual, 2025-12-31) — Pretax Income: -344894000.00
XENE income_statement (quarterly, 2025-12-31) — Pretax Income: -104723000.00
XENE cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 4962000.00
XENE cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1386000.00
XENE balance_sheet (annual, 2025-12-31) — Properties: 0.00
XENE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
XENE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -355657000.00
XENE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -60900000.00
XENE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -799000.00
XENE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -318000.00
XENE balance_sheet (annual, 2025-12-31) — Receivables: 1371000.00
XENE balance_sheet (quarterly, 2025-12-31) — Receivables: 1371000.00
XENE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2543000.00
XENE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 611000.00
XENE income_statement (annual, 2025-12-31) — Research And Development: 300938000.00
XENE income_statement (quarterly, 2025-12-31) — Research And Development: 87699000.00
XENE balance_sheet (annual, 2025-12-31) — Retained Earnings: -1245380000.00
XENE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1245380000.00
XENE cash_flow (annual, 2025-12-31) — Sale Of Investment: 574454000.00
XENE cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 123915000.00
XENE income_statement (annual, 2025-12-31) — Selling General And Administration: 79632000.00
XENE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 22068000.00
XENE balance_sheet (annual, 2025-12-31) — Share Issued: 80010790.00
XENE balance_sheet (quarterly, 2025-12-31) — Share Issued: 80010790.00
XENE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 53707000.00
XENE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 14115000.00
XENE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 581760000.00
XENE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 581760000.00
XENE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 581760000.00
XENE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 581760000.00
XENE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 202200.00
XENE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -44400.00
XENE income_statement (annual, 2025-12-31) — Tax Provision: 1016000.00
XENE income_statement (quarterly, 2025-12-31) — Tax Provision: 538000.00
XENE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
XENE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
XENE balance_sheet (annual, 2025-12-31) — Total Assets: 633163000.00
XENE balance_sheet (quarterly, 2025-12-31) — Total Assets: 633163000.00
XENE balance_sheet (annual, 2025-12-31) — Total Capitalization: 581760000.00
XENE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 581760000.00
XENE balance_sheet (annual, 2025-12-31) — Total Debt: 7944000.00
XENE balance_sheet (quarterly, 2025-12-31) — Total Debt: 7944000.00
XENE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 581760000.00
XENE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 581760000.00
XENE income_statement (annual, 2025-12-31) — Total Expenses: 380570000.00
XENE income_statement (quarterly, 2025-12-31) — Total Expenses: 109767000.00
XENE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 51403000.00
XENE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 51403000.00
XENE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 72514000.00
XENE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 72514000.00
XENE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9611000.00
XENE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9611000.00
XENE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -373070000.00
XENE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -109767000.00
XENE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 313000.00
XENE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 313000.00
XENE income_statement (annual, 2025-12-31) — Total Unusual Items: 1348000.00
XENE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -296000.00
XENE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1348000.00
XENE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -296000.00
XENE cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
XENE balance_sheet (annual, 2025-12-31) — Working Capital: 518857000.00
XENE balance_sheet (quarterly, 2025-12-31) — Working Capital: 518857000.00
XENE income_statement (quarterly, 2026-03-31) — +Operating Expense: 112328000.00
XENE income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
XENE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 5748000.00
XENE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1165000.00
XENE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 264879000.00
XENE balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 244874000.00
XENE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 87345717.00
XENE income_statement (quarterly, 2026-03-31) — Basic EPS: -1.17
XENE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 199163000.00
XENE balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 6288000.00
XENE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -133000.00
XENE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 7491000.00
XENE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2421833000.00
XENE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 545867000.00
XENE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1094747000.00
XENE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 843013000.00
XENE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -407282000.00
XENE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -88897000.00
XENE cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -302000.00
XENE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1801000.00
XENE cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1482000.00
XENE cash_flow (quarterly, 2026-03-31) — Change In Receivables: 205000.00
XENE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -3380000.00
XENE cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 205000.00
XENE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 346834000.00
XENE balance_sheet (quarterly, 2026-03-31) — Common Stock: 2421833000.00
XENE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1337819000.00
XENE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 837526000.00
XENE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 24606000.00
XENE balance_sheet (quarterly, 2026-03-31) — Current Assets: 1106632000.00
XENE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1561000.00
XENE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1561000.00
XENE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 39815000.00
XENE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 447000.00
XENE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 447000.00
XENE cash_flow (quarterly, 2026-03-31) — Depreciation: 587000.00
XENE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 587000.00
XENE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 587000.00
XENE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 87345717.00
XENE income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.17
XENE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -102302000.00
XENE income_statement (quarterly, 2026-03-31) — EBIT: -112328000.00
XENE income_statement (quarterly, 2026-03-31) — EBITDA: -111741000.00
XENE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -130000.00
XENE cash_flow (quarterly, 2026-03-31) — End Cash Position: 545867000.00
XENE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 843013000.00
XENE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -89030000.00
XENE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -400000.00
XENE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 548000.00
XENE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1211000.00
XENE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 23820000.00
XENE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 14582000.00
XENE income_statement (quarterly, 2026-03-31) — Interest Income: 6907000.00
XENE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 6907000.00
XENE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1337819000.00
XENE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -407282000.00
XENE balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 244874000.00
XENE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 244874000.00
XENE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 837526000.00
XENE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5930000.00
XENE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5930000.00
XENE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 837526000.00
XENE cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -204000.00
XENE income_statement (quarterly, 2026-03-31) — Net Income: -102302000.00
XENE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -102302000.00
XENE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -102302000.00
XENE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -102302000.00
XENE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -102302000.00
XENE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -102302000.00
XENE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -102302000.00
XENE income_statement (quarterly, 2026-03-31) — Net Interest Income: 6907000.00
XENE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -407149000.00
XENE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 6907000.00
XENE balance_sheet (quarterly, 2026-03-31) — Net PPE: 14582000.00
XENE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -133000.00
XENE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1337819000.00
XENE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 12417000.00
XENE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 12417000.00
XENE balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 8305000.00
XENE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -112289000.00
XENE income_statement (quarterly, 2026-03-31) — Normalized Income: -102836565.58
XENE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -88897000.00
XENE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -604000.00
XENE income_statement (quarterly, 2026-03-31) — Operating Income: -112328000.00
XENE income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
XENE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 96624123.00
XENE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 10720000.00
XENE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1211000.00
XENE income_statement (quarterly, 2026-03-31) — Other Gand A: 7801000.00
XENE income_statement (quarterly, 2026-03-31) — Other Income Expense: 548000.00
XENE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -539000.00
XENE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 3246000.00
XENE balance_sheet (quarterly, 2026-03-31) — Other Properties: 8294000.00
XENE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 548880000.00
XENE balance_sheet (quarterly, 2026-03-31) — Payables: 6017000.00
XENE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 30623000.00
XENE balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7631000.00
XENE income_statement (quarterly, 2026-03-31) — Pretax Income: -104873000.00
XENE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 5487000.00
XENE balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
XENE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -505652000.00
XENE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -133000.00
XENE balance_sheet (quarterly, 2026-03-31) — Receivables: 1165000.00
XENE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 587000.00
XENE income_statement (quarterly, 2026-03-31) — Research And Development: 88508000.00
XENE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1347682000.00
XENE income_statement (quarterly, 2026-03-31) — Salaries And Wages: 16019000.00
XENE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 98503000.00
XENE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 23820000.00
XENE balance_sheet (quarterly, 2026-03-31) — Share Issued: 96624123.00
XENE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 16894000.00
XENE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1337819000.00
XENE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1337819000.00
XENE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 13434.42
XENE income_statement (quarterly, 2026-03-31) — Tax Provision: -2571000.00
XENE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.02
XENE balance_sheet (quarterly, 2026-03-31) — Total Assets: 1386810000.00
XENE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1337819000.00
XENE balance_sheet (quarterly, 2026-03-31) — Total Debt: 7491000.00
XENE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1337819000.00
XENE income_statement (quarterly, 2026-03-31) — Total Expenses: 112328000.00
XENE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 48991000.00
XENE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 280178000.00
XENE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 9176000.00
XENE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -112328000.00
XENE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 269000.00
XENE income_statement (quarterly, 2026-03-31) — Total Unusual Items: 548000.00
XENE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 548000.00
XENE balance_sheet (quarterly, 2026-03-31) — Working Capital: 1066817000.00
XERS cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: -3000.00
XERS cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 702000.00
XERS cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
XERS income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -702000.00
XERS cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 38469000.00
XERS cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -54000.00
XERS balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 11825000.00
XERS balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 4942000.00
XERS cash_flow (annual, 2021-12-31) — Operating Gains Losses: 702000.00
XERS income_statement (annual, 2021-12-31) — Other Income Expense: -702000.00
XERS balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 35162000.00
XERS balance_sheet (annual, 2021-12-31) — Prepaid Assets: 4589000.00
XERS cash_flow (annual, 2021-12-31) — Sale Of Business: 38469000.00
XERS income_statement (annual, 2022-12-31) — +Operating Expense: 169554000.00
XERS income_statement (annual, 2022-12-31) — +Total Revenue: 110248000.00
XERS balance_sheet (annual, 2022-12-31) — Accounts Payable: 4606000.00
XERS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 30830000.00
XERS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -5534000.00
XERS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 599966000.00
XERS income_statement (annual, 2022-12-31) — Amortization: 10843000.00
XERS cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 10843000.00
XERS cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 10843000.00
XERS income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 10843000.00
XERS cash_flow (annual, 2022-12-31) — Amortization Of Securities: 184000.00
XERS income_statement (annual, 2022-12-31) — Basic Average Shares: 135628721.00
XERS income_statement (annual, 2022-12-31) — Basic EPS: -0.70
XERS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 67271000.00
XERS balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 3992000.00
XERS cash_flow (annual, 2022-12-31) — Capital Expenditure: -524000.00
XERS cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -524000.00
XERS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 10982000.00
XERS balance_sheet (annual, 2022-12-31) — Capital Stock: 14000.00
XERS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 121966000.00
XERS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 121966000.00
XERS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 127473000.00
XERS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 34461000.00
XERS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -102891000.00
XERS cash_flow (annual, 2022-12-31) — Change In Account Payable: -4318000.00
XERS cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -9607000.00
XERS cash_flow (annual, 2022-12-31) — Change In Inventory: -7465000.00
XERS cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -6179000.00
XERS cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 9680000.00
XERS cash_flow (annual, 2022-12-31) — Change In Payable: -4318000.00
XERS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -13925000.00
XERS cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -3887000.00
XERS cash_flow (annual, 2022-12-31) — Change In Receivables: -13374000.00
XERS cash_flow (annual, 2022-12-31) — Change In Working Capital: -35150000.00
XERS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -13374000.00
XERS cash_flow (annual, 2022-12-31) — Changes In Cash: 59043000.00
XERS balance_sheet (annual, 2022-12-31) — Common Stock: 14000.00
XERS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 45187000.00
XERS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 30000000.00
XERS cash_flow (annual, 2022-12-31) — Common Stock Payments: -468000.00
XERS income_statement (annual, 2022-12-31) — Cost Of Revenue: 22634000.00
XERS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 40204000.00
XERS balance_sheet (annual, 2022-12-31) — Current Assets: 186818000.00
XERS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1580000.00
XERS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1580000.00
XERS balance_sheet (annual, 2022-12-31) — Current Liabilities: 73621000.00
XERS balance_sheet (annual, 2022-12-31) — Current Provisions: 11173000.00
XERS cash_flow (annual, 2022-12-31) — Deferred Income Tax: -1424000.00
XERS cash_flow (annual, 2022-12-31) — Deferred Tax: -1424000.00
XERS cash_flow (annual, 2022-12-31) — Depreciation: 1825000.00
XERS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 12668000.00
XERS income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 10843000.00
XERS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 12668000.00
XERS income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 10843000.00
XERS income_statement (annual, 2022-12-31) — Diluted Average Shares: 135628721.00
XERS income_statement (annual, 2022-12-31) — Diluted EPS: -0.70
XERS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -94660000.00
XERS income_statement (annual, 2022-12-31) — EBIT: -81982000.00
XERS income_statement (annual, 2022-12-31) — EBITDA: -69314000.00
XERS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
XERS cash_flow (annual, 2022-12-31) — End Cash Position: 126314000.00
XERS cash_flow (annual, 2022-12-31) — Financing Cash Flow: 127473000.00
XERS balance_sheet (annual, 2022-12-31) — Finished Goods: 5958000.00
XERS cash_flow (annual, 2022-12-31) — Free Cash Flow: -103415000.00
XERS cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -1760000.00
XERS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 236000.00
XERS income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 1760000.00
XERS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -23000.00
XERS balance_sheet (annual, 2022-12-31) — Goodwill: 22859000.00
XERS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 143466000.00
XERS balance_sheet (annual, 2022-12-31) — Gross PPE: 15042000.00
XERS income_statement (annual, 2022-12-31) — Gross Profit: 87614000.00
XERS income_statement (annual, 2022-12-31) — Interest Expense: 14102000.00
XERS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 14102000.00
XERS income_statement (annual, 2022-12-31) — Interest Income: 2578000.00
XERS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 2578000.00
XERS cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 10859000.00
XERS balance_sheet (annual, 2022-12-31) — Interest Payable: 4656000.00
XERS balance_sheet (annual, 2022-12-31) — Inventory: 24735000.00
XERS balance_sheet (annual, 2022-12-31) — Invested Capital: 232262000.00
XERS cash_flow (annual, 2022-12-31) — Investing Cash Flow: 34461000.00
XERS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 30000000.00
XERS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 146214000.00
XERS balance_sheet (annual, 2022-12-31) — Leases: 5065000.00
XERS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 9402000.00
XERS balance_sheet (annual, 2022-12-31) — Long Term Debt: 187075000.00
XERS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 196477000.00
XERS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 146214000.00
XERS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -44233000.00
XERS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 2144000.00
XERS cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
XERS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 29532000.00
XERS balance_sheet (annual, 2022-12-31) — Net Debt: 65109000.00
XERS income_statement (annual, 2022-12-31) — Net Income: -94660000.00
XERS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -94660000.00
XERS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -94660000.00
XERS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -94660000.00
XERS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -94660000.00
XERS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -94660000.00
XERS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -94660000.00
XERS income_statement (annual, 2022-12-31) — Net Interest Income: -11524000.00
XERS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 34985000.00
XERS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 101981000.00
XERS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 101981000.00
XERS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -11524000.00
XERS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -4876000.00
XERS balance_sheet (annual, 2022-12-31) — Net PPE: 9508000.00
XERS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -98279000.00
XERS balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 3518000.00
XERS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 3518000.00
XERS income_statement (annual, 2022-12-31) — Normalized EBITDA: -66694000.00
XERS income_statement (annual, 2022-12-31) — Normalized Income: -92078829.36
XERS cash_flow (annual, 2022-12-31) — Operating Cash Flow: -102891000.00
XERS cash_flow (annual, 2022-12-31) — Operating Gains Losses: -301000.00
XERS income_statement (annual, 2022-12-31) — Operating Income: -81940000.00
XERS income_statement (annual, 2022-12-31) — Operating Revenue: 110248000.00
XERS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 136273090.00
XERS balance_sheet (annual, 2022-12-31) — Other Current Assets: 9287000.00
XERS balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2658000.00
XERS balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -23000.00
XERS income_statement (annual, 2022-12-31) — Other Income Expense: -2620000.00
XERS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 120607000.00
XERS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 3632000.00
XERS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4730000.00
XERS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 25719000.00
XERS balance_sheet (annual, 2022-12-31) — Other Properties: 3841000.00
XERS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 0.00
XERS income_statement (annual, 2022-12-31) — Other Special Charges: 1223000.00
XERS balance_sheet (annual, 2022-12-31) — Payables: 4606000.00
XERS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 44810000.00
XERS balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 13400000.00
XERS balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
XERS income_statement (annual, 2022-12-31) — Pretax Income: -96084000.00
XERS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 836000.00
XERS balance_sheet (annual, 2022-12-31) — Properties: 0.00
XERS cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
XERS balance_sheet (annual, 2022-12-31) — Raw Materials: 7410000.00
XERS balance_sheet (annual, 2022-12-31) — Receivables: 30830000.00
XERS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 20809000.00
XERS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 12668000.00
XERS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -44233000.00
XERS cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -468000.00
XERS income_statement (annual, 2022-12-31) — Research And Development: 20966000.00
XERS income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 3157000.00
XERS balance_sheet (annual, 2022-12-31) — Retained Earnings: -554770000.00
XERS cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
XERS cash_flow (annual, 2022-12-31) — Sale Of Investment: 34985000.00
XERS income_statement (annual, 2022-12-31) — Selling General And Administration: 137745000.00
XERS balance_sheet (annual, 2022-12-31) — Share Issued: 136273090.00
XERS income_statement (annual, 2022-12-31) — Special Income Charges: -4380000.00
XERS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 12160000.00
XERS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 45187000.00
XERS balance_sheet (annual, 2022-12-31) — Tangible Book Value: -98279000.00
XERS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -38829.36
XERS income_statement (annual, 2022-12-31) — Tax Provision: -1424000.00
XERS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.01
XERS balance_sheet (annual, 2022-12-31) — Total Assets: 344522000.00
XERS balance_sheet (annual, 2022-12-31) — Total Capitalization: 232262000.00
XERS balance_sheet (annual, 2022-12-31) — Total Debt: 198057000.00
XERS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 45187000.00
XERS income_statement (annual, 2022-12-31) — Total Expenses: 192188000.00
XERS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 299335000.00
XERS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 157704000.00
XERS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 225714000.00
XERS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -81940000.00
XERS income_statement (annual, 2022-12-31) — Total Unusual Items: -2620000.00
XERS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -2620000.00
XERS balance_sheet (annual, 2022-12-31) — Work In Process: 11367000.00
XERS balance_sheet (annual, 2022-12-31) — Working Capital: 113197000.00
XERS income_statement (annual, 2023-12-31) — +Operating Expense: 179279000.00
XERS income_statement (annual, 2023-12-31) — +Total Revenue: 163914000.00
XERS balance_sheet (annual, 2023-12-31) — Accounts Payable: 11565000.00
XERS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 39197000.00
XERS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -6036000.00
XERS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 610254000.00
XERS income_statement (annual, 2023-12-31) — Amortization: 10843000.00
XERS cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 10843000.00
XERS cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 10843000.00
XERS income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 10843000.00
XERS cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1263000.00
XERS income_statement (annual, 2023-12-31) — Basic Average Shares: 137674857.00
XERS income_statement (annual, 2023-12-31) — Basic EPS: -0.45
XERS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 126314000.00
XERS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 23204000.00
XERS cash_flow (annual, 2023-12-31) — Capital Expenditure: -2263000.00
XERS cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -2263000.00
XERS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 38259000.00
XERS balance_sheet (annual, 2023-12-31) — Capital Stock: 14000.00
XERS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 67449000.00
XERS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 72451000.00
XERS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -1613000.00
XERS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -6004000.00
XERS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -47023000.00
XERS cash_flow (annual, 2023-12-31) — Change In Account Payable: 6959000.00
XERS cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -524000.00
XERS cash_flow (annual, 2023-12-31) — Change In Inventory: -14804000.00
XERS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 818000.00
XERS cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 6418000.00
XERS cash_flow (annual, 2023-12-31) — Change In Payable: 6959000.00
XERS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 6435000.00
XERS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 3206000.00
XERS cash_flow (annual, 2023-12-31) — Change In Receivables: -8367000.00
XERS cash_flow (annual, 2023-12-31) — Change In Working Capital: -6294000.00
XERS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -8367000.00
XERS cash_flow (annual, 2023-12-31) — Changes In Cash: -54640000.00
XERS balance_sheet (annual, 2023-12-31) — Common Stock: 14000.00
XERS balance_sheet (annual, 2023-12-31) — Common Stock Equity: -6782000.00
XERS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
XERS cash_flow (annual, 2023-12-31) — Common Stock Payments: -1009000.00
XERS income_statement (annual, 2023-12-31) — Cost Of Revenue: 28645000.00
XERS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 28703000.00
XERS balance_sheet (annual, 2023-12-31) — Current Assets: 156264000.00
XERS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3495000.00
XERS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 3495000.00
XERS balance_sheet (annual, 2023-12-31) — Current Liabilities: 95193000.00
XERS balance_sheet (annual, 2023-12-31) — Current Provisions: 14198000.00
XERS cash_flow (annual, 2023-12-31) — Deferred Income Tax: -1249000.00
XERS cash_flow (annual, 2023-12-31) — Deferred Tax: -1249000.00
XERS cash_flow (annual, 2023-12-31) — Depreciation: 2317000.00
XERS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 13160000.00
XERS income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 10843000.00
XERS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 13160000.00
XERS income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 10843000.00
XERS income_statement (annual, 2023-12-31) — Diluted Average Shares: 137674857.00
XERS income_statement (annual, 2023-12-31) — Diluted EPS: -0.45
XERS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -62255000.00
XERS income_statement (annual, 2023-12-31) — EBIT: -36895000.00
XERS income_statement (annual, 2023-12-31) — EBITDA: -23735000.00
XERS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
XERS cash_flow (annual, 2023-12-31) — End Cash Position: 71674000.00
XERS cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1613000.00
XERS balance_sheet (annual, 2023-12-31) — Finished Goods: 10475000.00
XERS cash_flow (annual, 2023-12-31) — Free Cash Flow: -49286000.00
XERS cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -1000.00
XERS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 321000.00
XERS income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1000.00
XERS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -25000.00
XERS balance_sheet (annual, 2023-12-31) — Goodwill: 22859000.00
XERS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 132623000.00
XERS balance_sheet (annual, 2023-12-31) — Gross PPE: 35211000.00
XERS income_statement (annual, 2023-12-31) — Gross Profit: 135269000.00
XERS income_statement (annual, 2023-12-31) — Interest Expense: 26609000.00
XERS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 26609000.00
XERS income_statement (annual, 2023-12-31) — Interest Income: 4751000.00
XERS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 4751000.00
XERS cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 27686000.00
XERS balance_sheet (annual, 2023-12-31) — Interest Payable: 1374000.00
XERS balance_sheet (annual, 2023-12-31) — Inventory: 38838000.00
XERS balance_sheet (annual, 2023-12-31) — Invested Capital: 184150000.00
XERS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -6004000.00
XERS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
XERS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
XERS balance_sheet (annual, 2023-12-31) — Leases: 5984000.00
XERS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 34764000.00
XERS balance_sheet (annual, 2023-12-31) — Long Term Debt: 190932000.00
XERS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 225696000.00
XERS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
XERS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
XERS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1870000.00
XERS cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
XERS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1009000.00
XERS balance_sheet (annual, 2023-12-31) — Net Debt: 123483000.00
XERS income_statement (annual, 2023-12-31) — Net Income: -62255000.00
XERS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -62255000.00
XERS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -62255000.00
XERS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -62255000.00
XERS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -62255000.00
XERS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -62255000.00
XERS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -62255000.00
XERS income_statement (annual, 2023-12-31) — Net Interest Income: -21858000.00
XERS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -3741000.00
XERS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
XERS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
XERS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -21858000.00
XERS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1185000.00
XERS balance_sheet (annual, 2023-12-31) — Net PPE: 29175000.00
XERS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -139405000.00
XERS balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2268000.00
XERS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2268000.00
XERS income_statement (annual, 2023-12-31) — Normalized EBITDA: -26099000.00
XERS income_statement (annual, 2023-12-31) — Normalized Income: -64572504.72
XERS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -47023000.00
XERS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 2837000.00
XERS income_statement (annual, 2023-12-31) — Operating Income: -44010000.00
XERS income_statement (annual, 2023-12-31) — Operating Revenue: 163914000.00
XERS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 138130715.00
XERS balance_sheet (annual, 2023-12-31) — Other Current Assets: 5778000.00
XERS balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 20276000.00
XERS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -25000.00
XERS income_statement (annual, 2023-12-31) — Other Income Expense: 2364000.00
XERS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 109764000.00
XERS cash_flow (annual, 2023-12-31) — Other Non Cash Items: -2675000.00
XERS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 4540000.00
XERS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 6227000.00
XERS balance_sheet (annual, 2023-12-31) — Other Properties: 4153000.00
XERS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 5002000.00
XERS income_statement (annual, 2023-12-31) — Other Special Charges: 2837000.00
XERS balance_sheet (annual, 2023-12-31) — Payables: 11565000.00
XERS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 40268000.00
XERS balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 16956000.00
XERS balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
XERS income_statement (annual, 2023-12-31) — Pretax Income: -63504000.00
XERS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 581000.00
XERS balance_sheet (annual, 2023-12-31) — Properties: 0.00
XERS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -43741000.00
XERS balance_sheet (annual, 2023-12-31) — Raw Materials: 17404000.00
XERS balance_sheet (annual, 2023-12-31) — Receivables: 39197000.00
XERS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 26328000.00
XERS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 13160000.00
XERS cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
XERS cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1009000.00
XERS income_statement (annual, 2023-12-31) — Research And Development: 22341000.00
XERS income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -5200000.00
XERS balance_sheet (annual, 2023-12-31) — Retained Earnings: -617025000.00
XERS cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
XERS cash_flow (annual, 2023-12-31) — Sale Of Investment: 40000000.00
XERS income_statement (annual, 2023-12-31) — Selling General And Administration: 146095000.00
XERS balance_sheet (annual, 2023-12-31) — Share Issued: 138130715.00
XERS income_statement (annual, 2023-12-31) — Special Income Charges: 2363000.00
XERS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 10716000.00
XERS balance_sheet (annual, 2023-12-31) — Stockholders Equity: -6782000.00
XERS balance_sheet (annual, 2023-12-31) — Tangible Book Value: -139405000.00
XERS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 46495.28
XERS income_statement (annual, 2023-12-31) — Tax Provision: -1249000.00
XERS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.02
XERS balance_sheet (annual, 2023-12-31) — Total Assets: 322602000.00
XERS balance_sheet (annual, 2023-12-31) — Total Capitalization: 184150000.00
XERS balance_sheet (annual, 2023-12-31) — Total Debt: 229191000.00
XERS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -6782000.00
XERS income_statement (annual, 2023-12-31) — Total Expenses: 207924000.00
XERS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 329384000.00
XERS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 166338000.00
XERS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 234191000.00
XERS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -44010000.00